CVS Health (NYSE:CVS) Sets New 12-Month Low - Here's What Happened

Shares of CVS Health Co. (NYSE:CVS - Get Free Report) hit a new 52-week low on Monday . The stock traded as low as $43.56 and last traded at $43.71, with a volume of 1630925 shares traded. The stock had previously closed at $44.36.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on CVS shares. Mizuho dropped their price target on shares of CVS Health from $73.00 to $66.00 and set an "outperform" rating on the stock in a research note on Thursday, October 24th. TD Cowen lifted their target price on shares of CVS Health from $73.00 to $80.00 and gave the company a "buy" rating in a research report on Monday, November 25th. UBS Group upped their price target on shares of CVS Health from $60.00 to $62.00 and gave the stock a "neutral" rating in a research report on Thursday, November 7th. StockNews.com cut CVS Health from a "hold" rating to a "sell" rating in a report on Thursday, November 14th. Finally, Cantor Fitzgerald reissued a "neutral" rating and set a $62.00 target price on shares of CVS Health in a report on Tuesday, October 1st. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and thirteen have issued a buy rating to the company's stock. Based on data from MarketBeat.com, CVS Health presently has an average rating of "Moderate Buy" and an average target price of $69.12.

CVS Health Stock Down 0.5 %

The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59. The stock has a market capitalization of $55.55 billion, a price-to-earnings ratio of 11.20, a PEG ratio of 0.85 and a beta of 0.54. The business has a fifty day moving average of $56.24 and a 200 day moving average of $58.21.

CVS Health (NYSE:CVS - Get Free Report) last announced its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating analysts' consensus estimates of $1.08 by $0.01. The business had revenue of $95.43 billion during the quarter, compared to analysts' expectations of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The business's revenue for the quarter was up 6.3% on a year-over-year basis. During the same period last year, the business earned $2.21 earnings per share. As a group, equities analysts predict that CVS Health Co. will post 5.32 earnings per share for the current year.

Institutional Trading of CVS Health

A number of large investors have recently modified their holdings of the stock. MidAtlantic Capital Management Inc. acquired a new position in CVS Health during the 3rd quarter worth approximately $25,000. Livelsberger Financial Advisory acquired a new position in shares of CVS Health during the third quarter worth $31,000. Legacy Investment Solutions LLC acquired a new stake in CVS Health in the third quarter valued at $31,000. Reston Wealth Management LLC acquired a new position in shares of CVS Health during the 3rd quarter worth about $32,000. Finally, Kathleen S. Wright Associates Inc. purchased a new position in shares of CVS Health in the 3rd quarter valued at about $33,000. Hedge funds and other institutional investors own 80.66% of the company's stock.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.